News & Events

The latest news and events from OriCol™
London and Cambridge, UK, 14 March 2017: Fred Hutchinson Cancer Research Center (Fred Hutch) has selected Origin Sciences’ novel mucosal sampling device OriCol™ for use in sample collection as part of a phase I HIV study.
Read more...
New study will improve diagnosis of Inflammatory Bowel Disease
Read more...
Big pharma and venture capitalists alike are increasingly keen to understand and exploit the functions of genetic material of the microorganisms in the human body.
Read more...
London and Cambridge, UK, 26th October 2015: Origin Sciences Ltd, a medical technology company developing unique sampling devices and diagnostics for the stratification of patients with gastrointestinal diseases, today announced the launch of the OriCol™ Microbiome Research Kit.
Read more...
London and Cambridge, UK, 14 October 2015: Origin Sciences Ltd, a medical technology company developing unique sampling devices and diagnostics for the stratification of patients with gastrointestinal diseases, has appointed Paul Weinberger as a company director and Chief Executive.
Read more...
London and Cambridge, 1st April 2015 : Origin Sciences Ltd, a medical technology company developing innovative diagnostics and devices for investigating GI diseases, has published new data showing the effectiveness of its OriCol™ sampling device in gut microbiome research and…
Read more...

To place an order or for further information please email sales@originsciences.com or call +44 (0)1223 750490

Origin Sciences is based in the UK
with a laboratory in Cambridge
and offices in London.

Contact Us

1 Riverside, Granta Park, Great Abington, Cambridge, CB21 6AD, UK

6 Arlington Street, London, SW1A 1RE, UK

sales@originsciences.com
Tel: +44 (0)1223 750490

Newsletter Signup

* indicates required
 

How to order

To place an order or for further information please email sales@originsciences.com
or call +44 (0)1223 750490

Email us now